Sign inGet started

Preston Heather

Insider CIK 1606826 · ALBO Director · ALDR Director · OTIC Director · AKUS Director · ETTX Director, 10% owner · KRTX Director · ALGS Director · FUSN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALGS Aligos Therapeutics, Inc. A Award deriv2026-06-252026-06-295,860— $05,860SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2025-06-252025-06-265,860— $05,860SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2024-08-072024-08-09120,000— $0120,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2023-06-142023-06-1417,000— $017,000SEC↗
AKUS Akouos, Inc. D To issuer deriv2022-12-012022-12-0216,000— $00SEC↗
AKUS Akouos, Inc. U Tender2022-11-302022-12-025,882— $00SEC↗
AKUS Akouos, Inc. A Award deriv2022-06-232022-06-2716,000— $016,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2022-06-142022-06-2217,000— $017,000SEC↗
AKUS Akouos, Inc. A Award deriv2021-06-242021-06-2516,000— $016,000SEC↗
KRTX Karuna Therapeutics, Inc. J Other2021-06-242021-06-28184— $06,556SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2021-06-162021-06-238,500— $08,500SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2021-06-042021-06-0717,000— $017,000SEC↗
KRTX Karuna Therapeutics, Inc. J Other2021-03-082021-03-10572— $06,372SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-09-042020-09-09350$72.36 $25.3K5,800SEC↗
AKUS Akouos, Inc. C Conversion deriv2020-06-302020-07-021,499,971— $00SEC↗
FUSN Fusion Pharmaceuticals Inc P Buy2020-06-302020-07-028,823$17.00 $150.0K8,823SEC↗
AKUS Akouos, Inc. P Buy2020-06-302020-07-02294,117$17.00 $5.00M1,794,088SEC↗
AKUS Akouos, Inc. P Buy2020-06-302020-07-025,882$17.00 $100.0K5,882SEC↗
AKUS Akouos, Inc. C Conversion2020-06-302020-07-021,499,971— $01,499,971SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2020-06-252020-06-3030,000— $030,000SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2020-06-042020-06-0812,500— $012,500SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-03-122020-03-12500$70.00 $35.0K4,450SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-03-122020-03-12550$69.17 $38.0K3,950SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-03-122020-03-12500$73.00 $36.5K4,950SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-03-122020-03-12500$74.91 $37.5K5,450SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-03-102020-03-121,000$80.00 $80.0K3,400SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-01-092020-01-10788$70.50 $55.6K2,400SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-01-032020-01-071,138$70.00 $79.7K1,612SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2020-01-032020-01-07289$69.00 $19.9K474SEC↗
KRTX Karuna Therapeutics, Inc. P Buy2019-12-312020-01-03185$70.00 $12.9K185SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-2415,000— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-246,350— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-2415,000— $00SEC↗
KRTX Karuna Therapeutics, Inc. A Award deriv2019-06-272019-07-0116,250— $016,250SEC↗
ETTX Entasis Therapeutics Holdi A Award deriv2019-06-192019-06-217,500— $07,500SEC↗
OTIC OTONOMY, INC. A Award deriv2019-06-112019-06-1317,500— $017,500SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-029,502,249— $00SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-027,446,904— $00SEC↗
ETTX Entasis Therapeutics Holdi C Conversion2018-09-282018-10-02458,425— $0842,454SEC↗
ETTX Entasis Therapeutics Holdi P Buy2018-09-282018-10-02337,724$15.00 $5.07M1,180,178SEC↗
ETTX Entasis Therapeutics Holdi C Conversion2018-09-282018-10-02359,267— $0359,267SEC↗
OTIC OTONOMY, INC. A Award deriv2018-06-192018-06-2017,500— $017,500SEC↗
OTIC OTONOMY, INC. A Award deriv2017-06-202017-07-1415,000— $015,000SEC↗
ALDR ALDER BIOPHARMACEUTICALS I A Award deriv2017-05-242017-05-2615,000— $015,000SEC↗
ALBO ALBIREO PHARMA, INC. A Award deriv2017-01-232017-01-254,500— $04,500SEC↗
OTIC Otonomy, Inc. A Award deriv2016-06-212016-06-2115,000— $015,000SEC↗
ALDR ALDER BIOPHARMACEUTICALS I A Award deriv2016-05-262016-06-0215,000— $015,000SEC↗
OTIC Otonomy, Inc. A Award deriv2015-06-192015-06-2215,000— $015,000SEC↗
ALDR ALDER BIOPHARMACEUTICALS I A Award deriv2015-05-192015-05-216,350— $06,350SEC↗